Inhibition of oxidized low-density lipoprotein with orticumab inhibits coronary inflammation and reduces residual inflammatory risk in psoriasis: a pilot randomized, double-blind placebo-controlled trial.
作者信息
Farina Christopher J, Davidson Michael H, Shah Prediman K, Stark Charles, Lu Wenqi, Shirodaria Cheerag, Wright Timothy, Antoniades Charalambos A, Nilsson Jan, Mehta Nehal N
机构信息
Abcentra, 1925 Century Park E #1700, Los Angeles, CA 90067, USA.
Department of Medicine, University of Chicago Medical Center, Chicago, IL, USA.
出版信息
Cardiovasc Res. 2024 May 29;120(7):678-680. doi: 10.1093/cvr/cvae057.
Abstract
摘要
Zotero 插件